Physician profile
James P Cavanagh
NPI 1376540484
$1,248.49
in general payments reported to CMS, 2019-2025
17 companies · $383 in 2025
The $383 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.03 · 2021: $86.75 · 2022: $133 · 2023: $270 · 2024: $349 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $195.00 | 2022-2025 | |
| Exact Sciences Corporation | $177.37 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $159.59 | 2022-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Viatris Specialty LLC | $124.89 | 2025 | Yupelri |
| Sanofi Pasteur INC. | $109.32 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $86.80 | 2021-2023 | Xarelto |
| Daiichi Sankyo INC. | $58.93 | 2023 | Injectafer |
| Lilly USA, LLC | $54.78 | 2023-2025 | Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $47.65 | 2024-2025 | Breztri, Farxiga |
| Novo Nordisk INC | $40.25 | 2021-2024 | |
| Cranial Technologies, INC | $38.44 | 2024-2025 | Doc Band |
| Abbvie INC. | $37.18 | 2021 | |
| Baxter Healthcare | $30.10 | 2024 | Hillrom - Connex Spot Monitor |
| Astellas Pharma US INC | $26.03 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.39 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $22.07 | 2022 | |
| Upsher-Smith Laboratories LLC | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cavanagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.